Back to fellows
Profile Background
profile

Dr
Stephen Ian Walimbwa

Switzerland
Uganda

Related fellows

Dr Moses Egesa

Mr Mahamat Alio

View
Dr Moses Egesa

Mrs Justina Magalhães Bramugy

Junior Researcher

View
Dr Moses Egesa

Dr Chika Felicitas Nnadozie

Researcher

View
Show more

Project Title

Novartis Institute of Biomedical Research, Basel, Switzerland

Project Objectives

To acquire skills and knowledge, as well as to demonstrate expertise in the design, set-up, operationalization and follow-up of phase 1 and 2a clinical trials.

Results & Outcomes

The EDCTP-TDR Research & Development Fellowship supports researchers and key members of clinical trial research teams from Low and Middle Income Countries (LMICs) to acquire specific skills in clinical research and development through placements in pharmaceutical companies, product development partnerships (PDPs) and research institutions. Dr. Walimbwa was hosted for one year at the Novartis Institutes for Biomedical Research (NIBR) in Basel, Switzerland. Under the mentorship of NIBR scientists within translational medicine, he participated in clinical trials that provided early proof of efficacy in humans and clinical trials that profiled the safety, tolerability, pharmacokinetics (what the body does to the drug), and pharmacodynamics (effect of the drug on the body) of novel compounds. Some of these novel compounds will be key in management of autoimmune diseases, neglected tropical diseases, malaria and rare diseases. The EDCTP-TDR Research & Development Fellowship allowed Dr. Walimbwa receive training and acquire skills and expertise in the design, set-up, operationalization and follow-up of phase I-IIa clinical trials. Furthermore, the fellow was able to establish networks within Swiss academia and pharmaceutical industry which will provide opportunities for collaboration, career progression and development of strategies for tackling some poverty related diseases. The experience and expertise in early phase clinical trials will be vital to the Makerere University College of Health Sciences, Infectious Diseases Institute’s (IDI) Clinical Trial Unit’s capacity to undertake early phase clinical trials.

Host Organisation

Department Institution Country
Clinical Science and Inovation Novartis Institute of Biomedical Research, Basel CH
Infectious Diseases Institute UG

EDCTP Project

TMA2015-1166

EDCTP Program

EDCTP2

EDCTP Project Call

EDCTP Clinical Research & Development Fellowship (R&D F)

Study Design

12 Months placement at NIBR

Project Summary

The Fellow will be involved in the planning, management and evaluation of early phase clinical trials (Phase I and Phase Ila) under the assigned mentors at the Clinical Sciences and Innovation department within NIBR Translational Medicine (TM). TM studies are designed to profile the safety, tolerability, pharmacokinetics, and pharmacodynamics of novel compounds and to provide their early proof of efficacy in humans.